BIO.B

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

Director Hinckley Greg K converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 50% to 1,215 units (SEC Form 4)

Director Pei Melinda Litherland converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

Director Edwards Jeffrey L converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

Director Pinkston Arnold A converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

SEC Form DEF 14A filed by Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Regulation FD Disclosure

SEC Form 10-K filed by Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

EVP, President, LSG Barry James sold $214,289 worth of Bio-Rad A Common Stock (700 units at $306.18), decreasing direct ownership by 58% to 510 units (SEC Form 4)

SEC Form 144 filed by Bio-Rad Laboratories Inc.

SEC Form 10-Q filed by Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13D/A filed by Bio-Rad Laboratories Inc.

President & COO Divincenzo Jonathan P. converted options into 1,869 units of Bio-Rad A Common Stock and covered exercise/tax liability with 950 units of Bio-Rad A Common Stock (SEC Form 4)

EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 47% to 2,233 units (SEC Form 4)

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

EVP, Global Supply Chain Evran Sedat converted options into 864 units of Bio-Rad A Common Stock and covered exercise/tax liability with 277 units of Bio-Rad A Common Stock, increasing direct ownership by 63% to 1,524 units (SEC Form 4)

EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,535 units of Bio-Rad A Common Stock and covered exercise/tax liability with 550 units of Bio-Rad A Common Stock, increasing direct ownership by 115% to 1,844 units (SEC Form 4)

EVP, Global Human Resources Corey Colleen covered exercise/tax liability with 209 units of Bio-Rad A Common Stock and converted options into 576 units of Bio-Rad A Common Stock, increasing direct ownership by 2% to 19,550 units (SEC Form 4)

EVP, President, LSG Barry James converted options into 1,056 units of Bio-Rad A Common Stock and covered exercise/tax liability with 378 units of Bio-Rad A Common Stock, increasing direct ownership by 128% to 1,210 units (SEC Form 4)

Director Allison Schwartz converted options into 92 units of Bio-Rad A Common Stock and covered exercise/tax liability with 33 units of Bio-Rad A Common Stock, increasing direct ownership by 4% to 1,456 units (SEC Form 4)

SEC Form 4 filed by President & COO Divincenzo Jonathan P.

EVP, President, CDG Engelhardt Eva Anette covered exercise/tax liability with 413 units of Bio-Rad A Common Stock and converted options into 1,152 units of Bio-Rad A Common Stock, increasing direct ownership by 471% to 896 units (SEC Form 4)

EVP, General Counsel & Sec Enloe Courtney C converted options into 768 units of Bio-Rad A Common Stock and covered exercise/tax liability with 275 units of Bio-Rad A Common Stock, increasing direct ownership by 363% to 629 units (SEC Form 4)